When TNF inhibitors fail in RA—weighing up the options

被引：0
|
作者：
Lucia Silva-Fernandez
Kimme Hyrich
机构：
[1] Arthritis Research UK Centre for Epidemiology,
[2] Centre for Musculoskeletal Research,undefined
[3] Institute of Inflammation and Repair,undefined
[4] the University of Manchester,undefined
[5] Manchester Academic Health Science Centre,undefined
来源：
Nature Reviews Rheumatology | 2014年 / 10卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
What is the best rheumatoid arthritis therapy after failure of a first anti-TNF drug? No consensus has been reached on whether to switch to rituximab or an alternative TNF inhibitor. New observational studies suggest that either course can be effective. But are more data needed?
引用
收藏
页码：262 / 264
页数：2
相关论文
共 50 条
  • [41] WHEN ALL SHOCKS FAIL: SUBCUTANEOUS MANAGEMENT OPTIONS FOR SECONDARY PREVENTION OF VENTRICULAR ARRHYTHMIAS
    Gionfriddo, William
    Narayanan, Chockalingam
    Shrestha, Srijan
    Garlitski, Ann
    Weinstock, Jonathan
    Homoud, Munther
    Christopher, Madias
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 2078 - 2078
  • [42] Effectiveness of TNF inhibitors (TNF-I) in biologic naive and switched RA patients in a US cohort
    Greenberg, J.
    Gibofsky, A.
    Reed, G.
    Decktor, D.
    Dehoratius, R.
    Kremer, J.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S524 - S525
  • [43] Efficacy of ustekinumab in sub-erythrodermic psoriasis: when TNF-blockers fail
    Buggiani, Gionata
    D'Erme, Angelo Massimiliano
    Krysenka, Alena
    Pescitelli, Leonardo
    Lotti, Torello
    Prignano, Francesca
    DERMATOLOGIC THERAPY, 2012, 25 (03) : 283 - 285
  • [44] Direct cost of patients on TNF-α inhibitors for the treatment of rheumatoid arthritis (RA).
    Kerney, D
    Ollendorf, D
    Yu, EB
    Woolley, JM
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S509 - S509
  • [45] Effectiveness of TNF inhibitors in RA patients with moderate vs high disease activity
    Keystone, E.
    Reed, G.
    Hooper, M.
    Greeberg, J.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S779 - S779
  • [46] ANTINUCLEAR ANTIBODY POSITIVITY IN RA PATIENTS AND ITS IMPACT ON PERSISTENCY OF TNF INHIBITORS
    Sung, Y. -K.
    Cho, S. -K.
    Kim, D.
    Won, S.
    Choi, J. I.
    Choi, C. -B.
    Kim, T. -H.
    Jun, J. -B.
    Yoo, D. -H.
    Bae, S. -C.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 629 - 629
  • [47] Power Dopper Ultrasonography Detects Superior Efficacy of Non-TNF Biologics Compared to Cycling of TNF Inhibitors in RA Patients Inadequate Response to First TNF Inhibitors
    Nishino, Ayako
    Kawashiri, Shinya
    Yoshitama, Tamami
    Eiraku, Nobutaka
    Matsuoka, Naoki
    Ueki, Yukitaka
    Okada, Akitomo
    Hamada, Hiroaki
    Hidaka, Toshihiko
    Nagano, Shuji
    Tsuru, Tomomi
    Fujikawa, Keita
    Arinobu, Yojiro
    Tada, Yoshifumi
    Nagata, Yasuhiro
    Kawakami, Atsushi
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [48] Treatment-resistant depression: therapeutic options when first-line treatments fail
    Wigg, Chloe
    Costi, Sara
    BJPSYCH ADVANCES, 2022, 28 (01) : 4 - 8
  • [49] WHAT ARE THE PHARMACOLOGICAL OPTIONS WHEN ANTIDEPRESSANTS FAIL TO ACHIEVE REMISSION IN OBSESSIVE-COMPULSIVE DISORDER?
    Potts, Nicholas
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2013, 47 (S1): : 14 - 15
  • [50] Disease activity-guided TNF inhibitor dose reduction was noninferior to continuing TNF inhibitors for RA flares
    Ramirez-Lafita, Francisco
    ANNALS OF INTERNAL MEDICINE, 2015, 163 (06)
12345